Lexicon Genetics About
Lexicon Lexicon Genetics is a biopharmaceutical company
focused on the discovery of breakthrough treatments for human disease. Lexicon
is systematically discovering the physiological and behavioral functions of genes
to identify potential points of therapeutic intervention, or drug targets using
their technology to knock out, or disrupt, the function of dna(genes)
in mice. Lexicon has advanced more than 60 knockout-validated targets into drug
discovery programs in six therapeutic areas: diabetes
and obesity,
cardiovascular disease, psychiatric and neurological disorders, cancer,
immune
system disorders and ophthalmic disease.Their physiology-based approach to
understanding gene function and their use of knockouts to model expected drug
action are designed to identify new ways to treat major human diseases.
DRUG
PIPELINE -- Metabolism, Cardiology,
Cancer, Immunology, Neurology, Opthalmology More
on
Lexicon Home
Page for Lexicon
Basic Chart
for Lexicon